Search

Search bills, members, committees and pages...

KARUNA THERAPEUTICS

6 federal lobbying filings, 2023 to 2024.

KARUNA THERAPEUTICS is a client on 6 federal lobbying filings, 2023 to 2024, reporting $300K across them. Clinical-stage biopharmaceutical company. Based in Massachusetts.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
W STRATEGIES, LLC6$300K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20242$100K
20234$200K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues6

Lobbyists

Named on the filings.

LobbyistClientsFilings
DARREN WILLCOX16

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
KARUNA THERAPEUTICSW STRATEGIES, LLC2024 second_quarter$50KJul 22, 2024
KARUNA THERAPEUTICSW STRATEGIES, LLC2024 first_quarter$50KApr 22, 2024
KARUNA THERAPEUTICSW STRATEGIES, LLC2023 fourth_quarter$50KJan 19, 2024
KARUNA THERAPEUTICSW STRATEGIES, LLC2023 third_quarter$50KOct 20, 2023
KARUNA THERAPEUTICSW STRATEGIES, LLC2023 second_quarter$50KJul 20, 2023
KARUNA THERAPEUTICSW STRATEGIES, LLC2023 first_quarter$50KApr 20, 2023